Aditi Nayak(@AditiNayakMD) 's Twitter Profileg
Aditi Nayak

@AditiNayakMD

AHFTx👩🏻‍⚕️ @bswhealth via @BrighamWomens @harvardmed @EmoryMedicine. MS Bioinnovation @GeorgiaTech. Focus on device innovation for health disparities. #WIC.

ID:4757429335

calendar_today14-01-2016 09:47:09

1,4K Tweets

1,3K Followers

494 Following

Anu Lala-Trindade(@dranulala) 's Twitter Profile Photo

Hey peeps! Don’t you wish someone would distill HF 🫀 clinical trials at in 1️⃣ spot?

I know. Me too.

🙏🏽 Jennifer Maning, DO Clyde Yancy, MD, MSc Sanjiv J. Shah, MD & team for 🧏🏽‍♀️ me!! Journal of Cardiac Failure

🔥EMPACT-MI
🔥ARISE
🔥STEP-HFPEF DM
🔥RELIEVE-HF
🔥DANGER
🔥IMPROVE HCM…

Hey #FunctionNotFailure peeps! Don’t you wish someone would distill HF 🫀 clinical trials at #ACC24 in 1️⃣ spot? I know. Me too. 🙏🏽 @ManingJennifer @NMHheartdoc @HFpEF & team for 🧏🏽‍♀️ me!! @JCardFail 🔥EMPACT-MI 🔥ARISE 🔥STEP-HFPEF DM 🔥RELIEVE-HF 🔥DANGER 🔥IMPROVE HCM…
account_circle
Muthu Vaduganathan(@mvaduganathan) 's Twitter Profile Photo

.JACC Journals reference pocket cards for contemporary global guideline recommendations for drugs & devices in HF across the LVEF spectrum.🗒️

jacc.org/doi/10.1016/j.…

.@JACCJournals reference pocket cards for contemporary global guideline recommendations for drugs & devices in HF across the LVEF spectrum.🗒️ jacc.org/doi/10.1016/j.…
account_circle
Journal of Cardiac Failure(@JCardFail) 's Twitter Profile Photo

This month, is sharing the story of a patient’s journey to 🫀 transplantation – written from the patient's perspective!

A husband, a new father, a professional athlete ... & now a patient. Read part 1 of this powerful 3-part series, out now ⬇️

🔗bit.ly/3WbZ7YP

This month, #JCF is sharing the story of a patient’s journey to 🫀 transplantation – written from the patient's perspective! A husband, a new father, a professional athlete ... & now a patient. Read part 1 of this powerful 3-part series, out now ⬇️ 🔗bit.ly/3WbZ7YP
account_circle
Journal of Cardiac Failure(@JCardFail) 's Twitter Profile Photo

🔥 Out now in our April issue! 🌸

A State of the Art Review on Durable MCS devices by Seraina Dual & colleagues. Everything you need to know, including unmet needs, emerging technologies & the future of MCS.

🔗 bit.ly/3wC1QAf

🔥 Out now in our April issue! 🌸 A State of the Art Review on Durable MCS devices by @DualSeraina & colleagues. Everything you need to know, including unmet needs, emerging technologies & the future of MCS. 🔗 bit.ly/3wC1QAf
account_circle
JHLT(@TheJHLT) 's Twitter Profile Photo

In a multi-center cohort, the HM3 risk score provided adequate risk discrimination in “trial-like” pts but was less predictive in pts who did not meet trial criteria Ryan J Tedford MD Mandeep R. Mehra, MBBS, MSc, FRCP (London) Farooq Sheikh Jagpreet Grewal Alexander Hajduczok, MD 🇺🇦🙏

🔗 jhltonline.org/article/S1053-…

In a multi-center cohort, the HM3 risk score provided adequate risk discrimination in “trial-like” pts but was less predictive in pts who did not meet trial criteria @RyanTedfordMD @MRMehraMD @fsheikh22 @Jgrewal_12 @AHajduczok 🔗 jhltonline.org/article/S1053-…
account_circle
Cesar Guerrero-Miranda MD FACC(@ivguerrerom) 's Twitter Profile Photo

was unforgettable, shared ideas on & with colleagues worldwide. Humbled to talk about the evidence to achieve and Wean & share Baylor Scott & White Health system protocol, hope to inspire unified protocols & ideas to improve outcomes

#ISHLT2024 was unforgettable, shared ideas on #MCS & #LVAD with colleagues worldwide. Humbled to talk about the evidence #LVAD to achieve #myocardialrecovery and #LVADWean & share @bswhealth system protocol, hope to inspire unified protocols & ideas to improve #recovery outcomes
account_circle
Bernard Kadosh(@KadoshBernard) 's Twitter Profile Photo

Some of the most important contemporary work being done with LVADs. Bridge to recovery or delay of transplantation can mean many more years of life for some patients. The ISHLT Alex Reyentovich, MD Jason N. Katz

account_circle
Ivan Netuka(@netuka_ivan) 's Twitter Profile Photo

We are pleased to inform that our DOT-HM3 Trial results in partnership between IKEM and The Brigham Harvard just got online! Our results suggest a safety signal of Apixaban use with the HM3 up to a 6-months time point in stable LVAD patients. ahajournals.org/doi/abs/10.116…

We are pleased to inform that our DOT-HM3 Trial results in partnership between IKEM and The Brigham Harvard just got online! Our results suggest a safety signal of Apixaban use with the HM3 up to a 6-months time point in stable LVAD patients. ahajournals.org/doi/abs/10.116…
account_circle
JeanConnorsMD(@connors_md) 's Twitter Profile Photo

A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy with A Fully Magnetically Levitated LVAD: The DOT-HM3 Study | Circulation ahajournals.org/doi/10.1161/CI…
The ISHLT plenary presentation! Ivan Netuka Mandeep R. Mehra, MBBS, MSc, FRCP (London) Peter Ivak Zuzana Tucaniva 😀 colleagues

account_circle
Anu Lala-Trindade(@dranulala) 's Twitter Profile Photo

👀Wow what a jam packed issue! Please check out our Ed page relaying reflections of HFSA in India for Heart Failure Association of India in Delhi 🇮🇳 as well as analyses from STRONG-HF, STS-INTERMACS, 🔥 MCS review, 🫀shock working group, & much more!! Please check it out 👇🏽👇🏽👇🏽

👀Wow what a jam packed issue! Please check out our Ed page relaying reflections of @HFSA in India for @hfai20 in Delhi 🇮🇳 as well as analyses from STRONG-HF, STS-INTERMACS, 🔥 MCS review, 🫀shock working group, & much more!! Please check it out 👇🏽👇🏽👇🏽
account_circle
Aditi Nayak(@AditiNayakMD) 's Twitter Profile Photo

She slayed! Super proud of this ⭐️ who is already as nuanced in her understanding of the population as a general cardiology fellow. Watch out for her application to your general cardiology fellowship program in July 2024!


Jennifer Cowger

She slayed! Super proud of this ⭐️ who is already as nuanced in her understanding of the #AHFT population as a general cardiology fellow. Watch out for her application to your general cardiology fellowship program in July 2024! #ProudToBeHerMentor #NextGenAHFT @preventfailure
account_circle
Aditi Nayak(@AditiNayakMD) 's Twitter Profile Photo

👇🏽Please check out this important editorial by colleagues at Baylor Scott & White Dallas-Fort Worth making a strong case for always including a control group and accounting for measured CV risk in trials of therapeutics

academic.oup.com/cid/advance-ar…

account_circle
Robert Mentz, MD(@robmentz) 's Twitter Profile Photo

While it's super weird to get excited about emails from yourself (🤓), I love seeing the amazing content in the JCF Engage Newsletter each week!

What?! You're not getting this messages?!

Sign up here:
share.hsforms.com/1dKJCmfGKTAmua…

While it's super weird to get excited about emails from yourself (🤓), I love seeing the amazing content in the JCF Engage Newsletter each week! What?! You're not getting this messages?! Sign up here: share.hsforms.com/1dKJCmfGKTAmua…
account_circle
Anju Bhardwaj MD FACC(@docbhardwaj) 's Twitter Profile Photo

🔥🔥 Delighted to share our paper on ‘prehabilitation’ using Impella 5.5 & sharing our PT protocol
Ismael Salas MD FACS Amanda Bergeron Juan E Marcano MD Sachin Kumar et al.
Grateful to work with an amazing team of Surgeons, Cardiologists, ICU & PT team. 🙌🫀🫁
👉 journals.lww.com/asaiojournal/f…

🔥🔥 Delighted to share our paper on ‘prehabilitation’ using Impella 5.5 & sharing our PT protocol @IsmaelSalasMD @amanda_acnp @juanemarcano @MDSachinKumar et al. Grateful to work with an amazing team of Surgeons, Cardiologists, ICU & PT team. 🙌🫀🫁 👉 journals.lww.com/asaiojournal/f…
account_circle